SCHEMBL26847363

SCHEMBL26847363

C=C1NC(c2cccc(CSc3[nH]c(=O)cc(-c4cccs4)c3C#N)c2)=NO1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACMSD Q8TDX5 7/20 0.45
▸ CYP2C19 P33261 1/20 0.43
▸ KDM4E B2RXH2 5/20 0.38
▸ PIM1 P11309 2/20 0.38
▸ KMT2A Q03164 4/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ MAPT P10636 3/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ POLB P06746 2/20 0.37
▸ USP2 O75604 1/20 0.37
▸ PRNP P04156 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ BLM P54132 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ SAE1 Q9UBE0 1/20 0.37
▸ UBA2 Q9UBT2 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26847371 0.90 KDM4E (0.39) ACMSDCYP2C19KDM4EPIM1KMT2A
SCHEMBL26847367 0.88 KMT2A (0.40) ACMSDKDM4EKMT2AMEN1ALDH1A1
SCHEMBL26847309 0.87 ACMSD (0.39) ACMSDCYP2C19KDM4EKMT2AMEN1
SCHEMBL26847307 0.82 KMT2A (0.39) ACMSDKDM4EKMT2AMEN1ALDH1A1
SCHEMBL17548432 0.82 ACMSD (0.68) ACMSDCYP2C19KDM4EKMT2AMEN1
SCHEMBL24088014 0.80 ACMSD (0.68) ACMSDCYP2C19KDM4EPIM1KMT2A
SCHEMBL20340083 0.79 ACMSD (0.49) ACMSDCYP2C19KDM4EPIM1KMT2A
SCHEMBL26847368 0.79 HSD11B1 (0.36) ACMSDCYP2C19KMT2AMEN1ALDH1A1
SCHEMBL26847199 0.78 ACMSD (0.48) ACMSDCYP2C19KDM4EPIM1KMT2A
SCHEMBL26847313 0.78 ACMSD (0.32) ACMSDCYP2C19KMT2AMEN1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 ACMSD 1/4885CYP2C19 1550/4885KDM4E 1110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback